Biologic and Systemic Agents in Dermatology
-15%
portes grátis
Biologic and Systemic Agents in Dermatology
Yamauchi, Paul S.
Springer International Publishing AG
06/2019
574
Mole
Inglês
9783319883373
15 a 20 dias
2043
Descrição não disponível.
Chapter 1 - Tumor Necrosis Factor Inhibition in the Treatment of Psoriasis and Psoriatic Arthritis
Chapter 2 - Therapies Targeting Interleukin-23 in Psoriatic Disease
Chapter 3 - Interleukin 17 - Pathogenesis in Psoriatic Disease and Treatment through Selective Blockade
Chapter 4 - Conventional Systemic Agents for Psoriatic Disease
Chapter 5 - The Role of JAK Kinase Inhibitors in Psoriatic Disease and Other Dermatologic Conditions
Chapter 6 - PDE4 Inhibition in the Treatment of Psoriasis Disease and Other Skin Conditions
Chapter 7 - Miscellaneous Use of Biologic and Systemic Agents in Other Dermatologic Conditions
Chapter 8 - Targeting Interleukin 4 and Interleukin 13 in the Treatment of Atopic Dermatitis
Chapter 9 - Oral Agents for Atopic Dermatitis
Chapter 10 - Role of Intravenous Immunoglobulin in Dermatologic Disorders
Chapter 11 - Selective Targeting of CD20 on B Cells in Pemphigus Vulgaris and Other Dermatologic Diseases
Chapter 12 - Oral Systemic Agents for Various Immunobullous Disorders
Chapter 13 - Anti-IgE Therapy in Dermatology
Chapter 14 - Oral Retinoids in Dermatology
Chapter 15 - Updates in Immunotherapies for Melanoma
Chapter 16 - Sonic Hedgehog Inhibition in the Treatment of Advanced BCC
Chapter 2 - Therapies Targeting Interleukin-23 in Psoriatic Disease
Chapter 3 - Interleukin 17 - Pathogenesis in Psoriatic Disease and Treatment through Selective Blockade
Chapter 4 - Conventional Systemic Agents for Psoriatic Disease
Chapter 5 - The Role of JAK Kinase Inhibitors in Psoriatic Disease and Other Dermatologic Conditions
Chapter 6 - PDE4 Inhibition in the Treatment of Psoriasis Disease and Other Skin Conditions
Chapter 7 - Miscellaneous Use of Biologic and Systemic Agents in Other Dermatologic Conditions
Chapter 8 - Targeting Interleukin 4 and Interleukin 13 in the Treatment of Atopic Dermatitis
Chapter 9 - Oral Agents for Atopic Dermatitis
Chapter 10 - Role of Intravenous Immunoglobulin in Dermatologic Disorders
Chapter 11 - Selective Targeting of CD20 on B Cells in Pemphigus Vulgaris and Other Dermatologic Diseases
Chapter 12 - Oral Systemic Agents for Various Immunobullous Disorders
Chapter 13 - Anti-IgE Therapy in Dermatology
Chapter 14 - Oral Retinoids in Dermatology
Chapter 15 - Updates in Immunotherapies for Melanoma
Chapter 16 - Sonic Hedgehog Inhibition in the Treatment of Advanced BCC
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
systemic dermatology;biologic agents of dermatology;psoriasis;dermatology;atopic dermatitis;skin malignancies
Chapter 1 - Tumor Necrosis Factor Inhibition in the Treatment of Psoriasis and Psoriatic Arthritis
Chapter 2 - Therapies Targeting Interleukin-23 in Psoriatic Disease
Chapter 3 - Interleukin 17 - Pathogenesis in Psoriatic Disease and Treatment through Selective Blockade
Chapter 4 - Conventional Systemic Agents for Psoriatic Disease
Chapter 5 - The Role of JAK Kinase Inhibitors in Psoriatic Disease and Other Dermatologic Conditions
Chapter 6 - PDE4 Inhibition in the Treatment of Psoriasis Disease and Other Skin Conditions
Chapter 7 - Miscellaneous Use of Biologic and Systemic Agents in Other Dermatologic Conditions
Chapter 8 - Targeting Interleukin 4 and Interleukin 13 in the Treatment of Atopic Dermatitis
Chapter 9 - Oral Agents for Atopic Dermatitis
Chapter 10 - Role of Intravenous Immunoglobulin in Dermatologic Disorders
Chapter 11 - Selective Targeting of CD20 on B Cells in Pemphigus Vulgaris and Other Dermatologic Diseases
Chapter 12 - Oral Systemic Agents for Various Immunobullous Disorders
Chapter 13 - Anti-IgE Therapy in Dermatology
Chapter 14 - Oral Retinoids in Dermatology
Chapter 15 - Updates in Immunotherapies for Melanoma
Chapter 16 - Sonic Hedgehog Inhibition in the Treatment of Advanced BCC
Chapter 2 - Therapies Targeting Interleukin-23 in Psoriatic Disease
Chapter 3 - Interleukin 17 - Pathogenesis in Psoriatic Disease and Treatment through Selective Blockade
Chapter 4 - Conventional Systemic Agents for Psoriatic Disease
Chapter 5 - The Role of JAK Kinase Inhibitors in Psoriatic Disease and Other Dermatologic Conditions
Chapter 6 - PDE4 Inhibition in the Treatment of Psoriasis Disease and Other Skin Conditions
Chapter 7 - Miscellaneous Use of Biologic and Systemic Agents in Other Dermatologic Conditions
Chapter 8 - Targeting Interleukin 4 and Interleukin 13 in the Treatment of Atopic Dermatitis
Chapter 9 - Oral Agents for Atopic Dermatitis
Chapter 10 - Role of Intravenous Immunoglobulin in Dermatologic Disorders
Chapter 11 - Selective Targeting of CD20 on B Cells in Pemphigus Vulgaris and Other Dermatologic Diseases
Chapter 12 - Oral Systemic Agents for Various Immunobullous Disorders
Chapter 13 - Anti-IgE Therapy in Dermatology
Chapter 14 - Oral Retinoids in Dermatology
Chapter 15 - Updates in Immunotherapies for Melanoma
Chapter 16 - Sonic Hedgehog Inhibition in the Treatment of Advanced BCC
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
